Showing posts with label Journal of Diabetes research impact factor. Show all posts
Showing posts with label Journal of Diabetes research impact factor. Show all posts

Tuesday, 8 November 2022

Lupine Publishers| Variability in Plasma FGF21 Levels in Rats Fed A Standard 15% Protein Diet is not Sensitive Enough to Reflect Differences in Protein Requirements

 Lupine Publishers| Journal of Diabetes and Obesity



Introduction

Fibroblast growth factor 21 (FGF21) is a hepatokine member of a subfamily of “fibroblast growth factors” that responds to multiple metabolic stresses as protein deficiency [1-4]. FGF21 is produced in various tissues but the FGF21 circulating form is primarily of hepatic origin [1,2]. FGF21 affects numerous metabolic and behavioural parameters, and in particular, increases appetite for protein in subjects fed a protein-deprived diets [5,6]. In a recent still unpublished study, we observed that plasma FGF21 levels were higher in adult male Wistar rats fed a standard diet, formulated according the AIN93 recommendations for rats’ feed, containing 15% protein by energy [7] than in rats fed a 30% protein diet. In addition, inter-individual variability of plasma FGF21 levels was larger in rats fed the standard 15% protein diet than in rats fed the 30% protein diet. We therefore considered the hypothesis that higher levels and inter-individual variability in plasma FGF21 levels in rats fed a standard 15% protein diet would reflect the variability in protein requirements between individuals and thus, that measurement of plasma FGF21 levels can be used as a simple, rapid, and minimally-invasive test to estimate the adequacy of protein intake.
Dietary self-selection is a method that has been largely used in farm animals and laboratory rodents to study the requirements for macronutrients (carbohydrates, lipids and proteins), vitamins and minerals [8,9]. Many studies using this method, in our lab and others, showed that rats self-selecting between a protein diet and a protein-free diet often ingest up to 30-50% of total energy intake as protein [10-15], so much higher than the level considered as sufficient for an optimal growth in adult rats (10-15% by energy), which comforted our hypothesis that 15% dietary protein was possibly not the optimal dietary content.
The objective of this study was to verify that variability in plasma FGF21 levels in rats fed a standard 15% protein diet was indicative of differences in protein requirements. To this end, we have analyzed the relationship between FGF21 levels, and the level of protein subsequently selected during self-selection between a protein diet and a protein-free diet.

Experimental Procedure

24 adult male rats (215-240g) of the Wistar RccHan strain (ENVIGO) were used and individually housed (22°C ± 1°C, 12/12 L/D, cycle lights on at 08:00). After 1 week of adaptation to the laboratory conditions, the rats were fed for 12 days (Basal period) a standard diet formulated according to the AIN93 requirements [7] that contained 15% protein (15P); then, for 28 days (Choice period), 6 rats (Control group) continued to be fed with the standard diet and 18 (Self-selecting group) were given a choice between a pure protein diet (100P) and a protein-free diet containing a mix of fat (soy oil) and carbohydrate (corn starch and sucrose) in which carbohydrate amounted 60% by energy. The diets were provided, as necessary.

The food pellets were prepared twice a week by mixing the macronutrients, vitamins, and mineral mix with the amount of water required to make a thick dough. Food intake (g/day) was measured twice a week and converted in kJ/day based on the energy content of the diets (Table 1).

Table 1: Composition and energy content of the 3 used diets.

lupinepublishers-openaccess-journal-diabetes-obesity

100P: diet containing only proteins; 60C: protein-free diet containing only lipids and carbohydrates and in which carbohydrates amounted 60% by energy; 15P: standard diet containing 15% of protein by energy.

Blood samples (0.5 mL) were collected from the tail vein in EDTA tubes: once during the basal period and once during the choice period. Blood collection was made in the morning (10:00- 12:00) in rats that were not previously fasted. Blood samples were centrifuged (5000g, 15min, 4°C) and the plasma stored at -20°C. Plasma FGF21 levels (pg/ml) were measured by ELISA tests using commercial kits from Bio Vendor (Mouse/Rat FGF-21 ELISA RD291108200R).

Statistical Analysis

Statistical tests were performed using RStudio software, 2015. Changes in protein intake and plasma FGF21 level were compared using mixed two-factor ANOVA tests (parameter ~ group*period), which were followed by the main effects analysis by Bonferroni adjusted pairwise comparisons. Values are presented as means ± standard error of the mean (SEM). Linear regression analysis was used to study the link between plasma FGF21 levels during the basal period and protein intake during the choice period and was performed using Excel software. Significance of correlations was assessed using the Pearson correlation coefficient. A threshold of P≤0.05 was chosen as significant.

Results and Discussion

Protein intake was similar between the control and selfselecting group during the basal period but increased by 80% in the self-selecting group during the choice period (+37.8 kJ/d, p<0.0001) (Figure 1). This response significantly increased the contribution of protein to total energy intake from 15.0% to 23.5% (p<0.001). Mean plasma FGF21 levels averaged ~1,100 pg/mL in both groups during the basal period and decreased to 131 pg/mL in self-selecting group during the choice period (P<0.001) (Figure 2). Finally, contrary to our hypothesis, not only did we not observe a positive correlation between plasma FGF21 levels during the basal period and protein intake during the choice period, but instead we observed a weak and inverse correlation (Figure 3).

Figure 1: Protein intake (kJ/d) according to diet group and period.
(*:0.05; **:0.01; ***:0.001; ****:0.0001) Values are represented as means ±SEM, only the p-value of the interaction of ANOVA tests are indicated.

Lupinepublishers-openaccess-journal-diabetes-obesity

Figure 2: FGF21 level in plasma (pg/ml) according to diet group and period.
(*:0.05; **:0.01; ***:0.001; ****:0.0001) Values are represented as means ±SEM, only the p-value of the interaction of ANOVA tests are indicated.

Lupinepublishers-openaccess-journal-diabetes-obesity

Figure 3: Protein intake (kJ/d) during the choice period as a function of plasma FGF21 levels during the basal period in the self-selecting group.

Lupinepublishers-openaccess-journal-diabetes-obesity

Conclusion

In conclusion, inter-individual variability in plasma FGF21 levels in rats fed a standard 15% protein diet did not appear to be a parameter sensitive enough to reflect inter-individual differences in protein requirements. Therefore, plasma FGF21 level cannot be used as a test to determine inter-individual variability in protein requirements in individuals. Nevertheless we observed that plasma FGF21 levels in P15 fed rats were ~7 fold higher than in selfselecting rats ingesting 23.5% protein, which points on the fact that changes in plasma FGF21 levels are very sensitive to dietary protein intake, even when protein intake is well above essential protein requirements (~8-10 % in adult male rats).

Read More About our Lupine Publishers Journal of Diabetes and Obesity Please Click on Below Link: 
https://diabetes-obesity-lupine-publishers.blogspot.com

Sunday, 21 November 2021

Lupine Publishers| Associated Risk Factors in Pre-diabetes and Type 2 Diabetes in Saudi Community

 Lupine Publishers| Journal of Diabetes and Obesity


Abstract

Background and Objective: The prevalence and incidence of type 2 diabetes mellitus (T2DM) are increasing worldwide. Pre diabetes is a high-risk state for the development of diabetes and its associated complications. This study aims to determine the associated risk factors among T2DM and pre diabetes patients among adult Saudi population.

Methods: For the present study, we analyzed participants who are older than 20 years old and had undergone a blood test to assess HbA1c. A total of 1095 were selected to be enrolled for the present study. All patients were from the population of the Primary health and Diabetic Centres at King Fahad Armed Forces Hospital. Participants were defined as having T2DM according to self-report, clinical reports, use of anti diabetic agents and HbA1c (≥6.5). Non T2DM participants were divided into normoglycemic or pre diabetic group as follows: HbA1c < 5.7, (normoglycemic) or HbA1c 5.7-6.4 (pre diabetes). Laboratory assessments included HbA1c, lipids, creatinine and urinary micro albumin.

Main results: Of the 1095 participants analyzed, 796 were women (72.7%). Age was 45.1±11.1 and BMI was 30.7±5.7. Hypertension had been diagnosed in 415 (38.2%) participants. Blood measurements revealed the following values: creatinine 68.2±22.0umol/L , Urine micro albumin (g/min) 55.4±200.3, total cholesterol levels 4.9±1.0mmol/L, high density lipoprotein 1.3±0.3mmol/L, triglyceride levels 1.5±0.7 and low density lipoprotein 3.0±0.9mmol/L. Of the overall 1095 analyzed participants, pre diabetes was present in 362(33.1%), 368(33.6%) were classified as T2DM and 365 (33.3%) as normoglycemic. When comparing pre diabetic with normoglycemic and T2DM population, pre diabetic subjects were more likely to have hypertension and higher triglyceride than normoglycemic but less than T2DM subjects. In addition, pre diabetic patients compared with T2DM ones had higher levels of low density lipoprotein and high density lipoprotein. Logistic regression analysis showed no significant association of any of the co variables with normoglycemic subjects in front of the pre diabetic reference group, whereas the odds of being in the diabetic group gets multiplied by 7.56 for each unitary increase in male gender (p< 0.0001, OR: 7.56, 95% CI 3.16-18.23). Also, individuals with hypertension had higher odds of being in the DM group than in the prediabetic (p<0 .0001, OR: 6.06, 95% CI 3.25- 11.28). Age of subjects had lower odds of being in the DM group than in the pre diabetic (p<0 .0001, OR: 0.85, 95% CI (0.82-0.89).

Conclusion: This study found the major clinical differences between pre diabetic and T2DM Patients were the higher hypertension and hypertriglyceridenia in the T2DM patients. Clearly, despite the small sample size, this study has posed important public health issues that require immediate attention from the health authority. Unless immediate steps are taken to contain the increasing prevalence of obesity, diabetes, pre diabetes, the health care costs for chronic diseases will pose an enormous financial burden to the country

Keywords: Type 2 Diabetes; Pre diabetes; Risk factors

Abbreviations: T2DM: Type 2 Diabetes Mellitus; IFG: Impaired Fasting Glucose; BMI: Body Mass Index; HTN: Hypertension; AER: Albumin Excretion Rate; DN: Diabetic Nephropathy; OR: Odds Ratio; CI: Confidence Interval; I-IFG: Isolated Impaired Fasting Glucose

Introduction

Diabetes mellitus is a major cause of excess mortality and morbidity. The prevalence and incidence of type 2 diabetes mellitus (T2DM) are increasing worldwide [1]. T2DM patients have a higher risk of developing microvascular and macrovascular disease than the general population. The occurrence of these complications depends largely on the degree of glycemic control as well as on the adequate control of cardiovascular risk factors [2-5]. In Saudi Arabia, primary epidemiological diabetes features are not different. The diabetes mellitus prevalence among adult Saudi population has reached 23.7%, a percentage being the highest across the globe [6,7]. Statistics regarding the increasing trend of diabetes and pre diabetes in the world have also been observed in Saudi Arabia. As per the WHO country profile 2016, 14.4% of Saudi population has diabetes, while prevalence in males is 14.7% [8]. In 2015, the prevalence of pre diabetics was found to be 9.0% in Jeddah with 9.4% in men, while for diabetes, it was 12.1% with 12.9% adult male population suffering from it [9]. Another study conducted in Saudi population revealed that the diabetes prevalence in their study was found to be 25.4%, while impaired fasting glucose (IFG) was 25.5%. The strongest risk factors were age > 45 years, high triglycerides levels, and hypertension [10].

Pre diabetes is a high-risk state for the development of diabetes and its associated complications [11-13].

Recent data have shown that in developed countries, such as the Unites States and the United Kingdom, more than one-third of adults have pre diabetes, but most of these individuals are unaware they have the condition [14-16]. Once detected, pre diabetes needs to be acknowledged with a treatment plan to prevent or slow the transition to diabetic [17,18]. Treatment of pre diabetes is associated with delay of the onset of diabetes [19]. Detection and treatment of pre diabetes is therefore a fundamental strategy in diabetes prevention [11].

Current recommendations for pre diabetes screening by the American Diabetes Association focus nearly exclusively on adults who are overweight or obese as defined by body mass index (BMI) until the patient meets the age-oriented screening at 45 years [11]. Further, the recently released recommendation from the US Preventive Services Task Force regarding screening for abnormal glucose levels and T2DM limits screening to individuals who are overweight or obese [20]. This focus on obese or overweight individuals, although obesity and pre diabetes have shown trends of increasing prevalence. United States Preventive Services Task Force has recommended screening of diabetes in adults devoid of precise symptoms and in individuals with BP higher than 135/80mmHg [21]. This study aims to determine the associated risk factors among T2DM and pre diabetes patients among adult Saudi population.

Methods

For the present study, we analyzed participants who are older than 20 years old and had undergone a blood test to assess HbA1c. A total of 1095 were selected to be enrolled for the present study. All patients were from the population of the Primary health and Diabetic Centers at King Fahad Armed Forces Hospital. Participants were defined as having T2DM according to self-report, clinical reports, use of anti diabetic agents and HbA1c (≥6.5) [11]. Non T2DM participants were divided into normoglycemic or pre diabetic group as follows: HbA1c<5.7, (normoglycemic) or HbA1c 5.7-6.4 (pre diabetes) [11]. 362 subjects were found to be pre diabetic. Almost similar number of normoglyceic and T2DM subjects was selected to be analyzed for comparison. All data were collected by personal interview and on the basis of a review of electronic medical data. Weight (kg) and height (cm) were measured by physician and nurse interviewers and recorded. Overweight and obesity were defined as BMI 25-29.9 and ≥30.0kg/m2 respectively [22]. Blood Pressure readings were within a gap of 15 minutes using a mercury sphygmomanometer by palpation and auscultation method in right arm in sitting position. Two readings were taken 15 min apart and the average of both the readings was taken for analysis. Hypertension (HTN) was also diagnosed based on anti HTN medications or having a prescription of antihypertensive drugs and were classified as Hypertensive irrespective of their current blood pressure reading or if the blood pressure was greater than 140/90 mmHg i.e. systolic BP more than 140 and diastolic BP more than 90 mm of Hg – Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [23]. Laboratory assessments included HbA1c, lipids, creatinine and urinary micro albumin. HbA1c was expressed as percentage. High performance liquid chromatography was used. Fasting serum lipids were measured on a sample of blood after fasting for 14 hours. We used the enzymatic method for determining the cholesterol and trigylcerides levels. Diabetic nephropathy (DN) was assessed by measurement of mean albumin excretion rate (AER) on timed, overnight urine collections. We use a polyclonal radioimmunoassay for albumin measurement. DN is defined as an albumin excretion rate of >20g/min in a timed or a 24hr urine collection which is an equivalent to >30 mg/g creatinine in a random spot sample.

Statistical Analysis

Univariate analysis of demographic and clinical laboratory was accomplished using one-way analysis of variance (ANOVA) with posy hoc analysis between variables, to estimate the significance of different between groups where appropriate. Chi square (X2) test were used for categorical data comparison. The adjusted odds ratio (OR) with a 95% confidence interval (CI) was calculated. In order to evaluate the adjusted association of aforementioned factors on being normoglycemic or diabetic in relation to the pre diabetes group, a multinomial logistic regression model was fit, in which the categorical dependent variable was normoglycemia, pre diabetes or T2DM(with pre diabetes as the reference category), and significant variables in bivariate analyses were included as explanatory variables. Despite of the ordinal nature of the dependent variable, ordered logistic regression was not adjusted because the aim of the study was not the association of factors with a latent degree of diabetes but the differential profile of pre diabetes in front of normoglicemia and diabetes. As all the participants were the same age, adjusting for age was not applied. All statistical analyses were performed using SPSS Version 22.0. The difference between groups was considered significant when P<0.05.

Results

Of the 1095 participants analyzed, 796 were women (72.7%). Age was 45.1±11.1 and BMI was 30.7±5.7. Hypertension had been diagnosed in 415 (38.2%) participants. Blood measurements revealed the following values: creatinine 68.2±22.0umol/L, Urine microalbumin (g/min) 55.4±200.3, total cholesterol levels 4.9±1.0mmol/L, high density lipoprotein 1.3±0.3mmol/L, triglyceride levels 1.5±0.7 and low density lipoprotein 3.0 ±0.9mmol/L. Of the overall 1095 analyzed participants, pre diabetes was present in 362(33.1%), 368(33.6%) were classified as T2DM and 365 (33.3%) as normoglycemic. Table 1 shows the clinical characteristics and laboratory data of the three groups according to the predefined glycemic status. When comparing pre diabetic with normoglycemic and T2DM population, pre diabetic subjects were more likely to have hypertension and higher triglyceride than normoglycemic but less than T2DM subjects. In addition, prediabetic patients compared with T2DM ones had higher levels of low density lipoprotein and high density lipoprotein. In Table 2, logistic regression analysis showed no significant association of any of the covariables with normoglycemic subjects in front of the pre diabetic reference group, whereas the odds of being in the diabetic group gets multiplied by 7.56 for each unitary increase in male gender (p<0.0001, OR: 7.56, 95% CI 3.16-18.23). Also, individuals with hypertension had higher odds of being in the DM group than in the pre diabetic (p<0 .0001, OR: 6.06, 95% CI 3.25-11.28). Age of subjects had lower odds of being in the DM group than in the pre diabetic (p<0 .0001, OR: 0.85, 95% CI (0.82-0.89).

Table 1: Characteristics of patients with Normoglycemia, prediabetes and type 2 diabetes mellitus.

lupinepublishers-openaccess-journal-diabetes-obesity

Data are means ± SD or number (%)

Table 2: Multinomial logistic regression results according to glycemic status. Association with clinical characteristics among prediabetic as a reference category.

lupinepublishers-openaccess-journal-diabetes-obesity

Discussion

This study showed that multiple risk factors are related to T2DM, but not to the pre diabetes group, including age, female gender and HTN. Generalization to all population could not be due to regionalized characteristics. In addition, it does not evaluate the healthcare services offered in our city. The size of our sample and the cross section type of the study should be of consideration.

T2DM is a major health concern worldwide and is increasing in parallel with the obesity epidemic [24]. Prevalence of T2DM has increased dramatically with 1 million people reported to have been diagnosed with T2DM in 1994, increasing to 382 million by 2013, and with prediction of 592 million by 2035 [25]. Given that both genetic and environmental factors contribute to T2DM progression, it has been proposed that amongst increasing globalization, Asian ethnicities including Saudi Arabia have been unable to adapt to food and lifestyle related aspects of westernized culture [26]. Hence when matched for the same gender, age, and body weight, those with Asian ethnicity appear to have a greater risk of poor metabolic health than Caucasian counterparts including Europeans people [27]. This increased risk for T2DM has been reported in both Asians and Saudi Arabia [6-10,28].

Currently, the population with pre-diabetes has reached approximately 318 million around the world, accounting for 6.7% of the total number of adults. About 69.2% of the prediabetes population lives in low or middle-income countries [29]. Understanding pre diabetes may be crucial to reducing the global T2DM epidemic and is defined either by the presence of isolated impaired fasting glucose (I-IFG); or isolated impaired glucose tolerance (I-IGT); or both IFG and IGT. To maintain glucose homeostasis greater secretion of insulin is required from the pancreatic cells, and hence hyperinsulinemia develops. Prolonged hyperinsulinemia and/or fatty pancreas may in turn lead to the dysfunction of pancreatic cells, resulting in impaired insulin secretion [30]. Decreased insulin secretion and concomitant increased blood glucose levels consequently also lead to the reduced uptake of glucose by skeletal muscle, thereby enhancing muscle insulin resistance [31]. IFG, determined from fasting plasma glucose, occurs as a result of poor glucose regulation, resulting in raised blood glucose even after an overnight fast, while IGT is due to an individual being unable to respond to glucose consumed as part of a meal, resulting in increased postprandial blood glucose [11]. More recently, prediabetes has also been identified by mildly elevated HbA1c [32,33].

The younger age of T2DM in our cohort is consistent with that seen among other groups such as the Australians, the American Indian and Alaska natives [34-36]. Age of subjects had lower odds of being in the DM group than in the pre diabetic (p<0 .0001, OR: 0.85, 95% CI (0.82-0.89) in concordance with earlier reports [37,38]. Odds of being in the diabetic group gets multiplied by 7.56 for each unitary increase in male gender (p< 0.0001, OR: 7.56, 95% CI 3.16- 18.23). As seen in this study, majority of the female participants were either overweight (59.6%) or obese (78.6%). The reason for such an observation has not been completely elucidated but is proposed to be associated with obesity which is highly prevalent in the populations worldwide. Since obesity is closely linked to increased insulin resistance and decreased insulin sensitivity and higher risk of diabetes, arresting the obesity pandemic among our population should be a priority [39-41]. Special, culturally oriented community-based intervention programs need to be implemented. The frequency of pre diabetes in 27.2% of the female cases out of the total cohort in this study was six times higher than other, estimated to be 4.2% in 2006 [42,43]. Due to our small sample size, this is inconclusive and needs to be verified by extending our study to more of our communities. Nevertheless, our findings warrant special attention from the health authorities since although HbA1c is not as sensitive as IGT test, it has consistently been shown to be a good predictor of increased risk for cardiovascular diseases and T2DM in many populations around the world [44,45].

Previous cross-sectional studies have reported that multiple risk factors are related to pre-diabetes, Such as increased age, overweight, obesity, blood pressure, and dyslipidemia [37,46,47]. More importantly, impaired glucose tolerance was found to be an independent risk factor for cardiovascular disease, the hazard ratio of death was 2.22 (95% CI = 1.08–4.58), and arterial stiffness and pathological changes in the arterial intima occurred in the stage of IGT [48]. The participants in our study with pre-diabetes had higher BMI, more frequent HTN, higher triglyceride, frequent renal failure and DN than those without pre-diabetes but lower than participants with T2DM. logistic regression analysis showed no significant association of any of the covariables with normoglycemic subjects in front of the pre diabetic reference group, whereas the odds of being in the diabetic group gets multiplied by 7.56 for each unitary increase in male gender. Also, individuals with hypertension had higher odds of being in the DM group than in the pre diabetic. Age of subjects had lower odds of being in the DM group than in the pre diabetic which was consistent with earlier studies [37,38].

Previous studies have reported that overweight and obesity were the mainly factors contributing to insulin resistance, and insulin resistance was the basis of diabetes and other chronic diseases [49,50]. In the present study, BMI was significantly higher in the pre diabetes than the normal groups, p=0.03. When BMI was classified into three types. The total numbers of overweight and obese people in the pre-diabetes and normal groups were 293 and 291, respectively (the total number were 362 and 365, respectively), and there were statistically non significant differences in being overweight or obese between the pre-diabetes and normal groups (OR = 1.02, 95% CI = 0.86–1.21, p=0.8). Increasing evidence suggests that the excess body fat in overweight/obese people might lead to increased degradation of fat, which resulted in the production of large amounts of free fatty acids (FFAs). When the level of FFAs was higher in blood, the capacity of liver tissue for insulin-mediated glucose uptake and utilization was lower, so the blood glucose level was high in circulation [51]. In other words, high FFAs in the blood were one of the important pathogenic factors of obesity caused by insulin resistance [52]. The fact that BMI categories was not a significant factor in our study is the cohort mean BMI was in the obesity range, p=0.3. However, the mean BMI was significantly different between the studied groups, p=0.03.

A high level of triglycerides was not significantly associated as a risk factor for developing pre-diabetes and T2DM (OR = 1.09, 95% CI = (0.60-2.00), P=0.8, 1.44(0.86-2.40),P=0.2) respectively. High level of triglycerides could increase the fat deposition in muscle, liver, and pancreas, and it could damage the function of mitochondria and induce oxidative stress which, in turn, could cause insulin resistance, but also lead to impaired islet B cell function [53]. Some studies suggested an interrelation between hyper triglyceridemia and insulin resistance and that they promote each other’s development [54,55]. In concordance with our result, in some epidemiological studies, for instance, the Framingham Heart Study, hyper triglyceridemia was more prevalent in type 2 diabetes mellitus patients than in the normal population, suggesting that hyper triglyceridemia is a causal factor of type 2 diabetes mellitus [56]. However, this paper was a cross-sectional study, thus it was impossible to determine the causal relationship between hyper triglyceridemia and pre-diabetes and T2DM.

Hypertension was found to be a risk factor for T2DM but not for the pre diabetes group in our study (OR = 6.06, 95% CI =3.25- 11.28, p<0.0001, OR = 0.95, 95% CI = 0.50-1.82, p=0.9) respectively. A possible mechanism is that the activity of angiotensin II is increased in the circulatory system of patient with hypertension. Angiotensin II activates renin-angiotensin-aldosterone system and affects the function of the pancreatic islets, resulting in islet fibrosis and reduced synthesis of insulin, and ultimately leading to insulin resistance [57,58]. Insulin resistance can also aggravate the condition of hypertension. Directly or indirectly through the activity of renin-angiotensin-aldosterone system, insulin promotes renal tubular to reabsorb Na+ and water, leading to the increased blood volume and cardiac output; this is considered as one of reasons for the development of hypertension [59]. Interactions between abnormal glucose tolerance, hypertension, and dyslipidemia could impair endothelial cell and result in atherosclerosis or other cardiovascular complications. Therefore, the management of daily diet of people with pre-diabetes and the monitoring of body weight, blood lipids, and blood pressure is very important.

Results of our investigation must be interpreted in light of some limitations such as the cross-sectional design, which does not let to establish any causal relation with respect to prediabetic state and only provides mere associations. Moreover, the classification of glycemic state was based on HbA1c, instead of its combination with a glucose tolerance test. Then, it is expected that the lack of glucose tolerance test data leads to a suboptimal estimation of glycemic state because normoglycemic group may include some individuals with impaired glucose tolerance that should have been included in pre diabetic group. Considering the goal population, a larger cohort would have probably provided a greater power of the statistical analyses.

Conclusion

This study found the major clinical differences between pre diabetic and T2DM patients were the higher hypertension and hyper triglyceridenia in the T2DM patients. Clearly, despite the small sample size, this study has posed important public health issues that require immediate attention from the health authority. Unless immediate steps are taken to contain the increasing prevalence of obesity, diabetes, pre diabetes, the health care costs for chronic diseases will pose an enormous financial burden to the country.

Conclusion

Use a plant based protein blend diet pea - lowers levels of hunger hormone, ghrelin. Quinoa -chock full of anti-inflammatory compounds called flavonoids. Hemp - contains 20 amino acids, healthy omega fats and fiber (including 9 the body cannot make on its own). Coconut - packed full of healthy saturated fats that go straight to the liver for a quick energy boost. Monk fruit - contains powerful antioxidants called mogrosides. Cinnamon - clinically proven to support healthy blood sugar levels AND healthy triglyceride levels. Vanilla Bean - loaded with minerals like magnesium, potassium, and calcium. Vanilla also has mood-boosting and energy enhancing effects on body. Zero alcohol use.

disease”.

Read More About Lupine Publishers Journal of Diabetes and Obesity Please Click on Below Link: https://diabetes-obesity-lupine-publishers.blogspot.com/


Wednesday, 25 August 2021

Lupine Publishers| Diet, Obesity and Diabetes

 Lupine Publishers| Archives of Diabetes & Obesity (ADO)


Abstract

Obesity and diabetes have become a very important global problem. In developed countries the incidence of both seems to have stabilised probably due to greater awareness and better education. Weight reduction in obese subjects with diabetes can be achieved by bariatric surgery and often results in remission of diabetes, hypertension and dyslipidaemia but at a cost of mortality and morbidity. Dietary intervention until recently has been relatively unsuccessful. Recently however, structured, low calorie diet with nurse/dietician support in a general practice setting has shown promise. Successful drug therapy to aid weight reduction remains elusive.

Opinion

There is a national awareness of the increasing prevalence of obesity and type 2 diabetes. The good news is that the rising trends in children’s BMI has plateaued in high income countries such as ours but it is sad that they have accelerated in parts of Asia and other regions [1]. Early development of obesity has been shown to predict obesity in adulthood especially for children who are severely obese [2]. An interesting recent article [3] examined overweight children at the age of 7, at 13, and early adulthood. The authors found that at any of these 3 stages overweight was positively associated with risk of type 2 diabetes. Men who had had remission of overweight before the age of 13 years, had a risk of having type 2 diabetes diagnosed at 30 to 60 years of age that was similar to that of men who had never been overweight. Thus there would seem to have been a window of opportunity for diabetes prevention between the age of 7 and 13. Type 2 Diabetes, hypertension and dyslipidaemia, can of course be reversed in many cases by weight reduction. The most impressive results have been obtained through Bariatric Surgery. Weight and metabolic outcomes 12 years after gastric bypass was reported by Adams et al. [4]. This was an observational prospective study of roux en y gastric bypass. Mean percentage body weight reduction in the surgery group was 45kg (mean % change in body weight was minus 35%) as compared to a reduction of minus 2% in the non surgery group. Diabetes remitted in 75% of the patients at 2 years and in 55% at 12 years. Hypertension and dyslipidaemia also remitted significantly more in the surgery group than in the non surgery group. The 12 year incidence of diabetes was 3% in the surgery group and 26% in the non surgery group. Alas there were 7 deaths by suicide, 5 in the surgery group and 2 in the non-surgery group who went on later to have bariatric surgery. This study and many others demonstrate the success of surgery in causing important weight loss and in reversing important cardiovascular risk factors such as hypertension, diabetes and dyslipidaemia. The morbidity and mortality make physicians and patients wary of the procedure and opt instead for calorie restriction, sometimes with drug therapy such as GLP1 agonists or appetite suppressants. Unfortunately the results only rarely match those of bariatric surgery.

In 2011 Lim et al. [5] published their seminal paper supporting the hypothesis that type 2 diabetes is caused specifically by fat in the liver and pancreas. They showed that on a negative energy balance with a 600-700 kcal/day diet. Liver insulin resistance and fat content normalised within 7 days with first phase insulin response and pancreatic fat content, normalising over 8 weeks. The underlying changes were shown to remain stable over the next 6 months of isocaloric eating. Unfortunately the popularity of this wonderfully successful treatment had not gained widespread acceptance even though it is virtually free from serious adverse events and mortality. However, it seems as if acceptance will dramatically increase in the next few years following the next important paper from Roy Taylors group [6]. The aim of their study was to assess whether intensive weight management in primary care would achieve remission of type 2 diabetes. Forty nine primary care practices in Scotland and the Tyneside region in England were involved. The patients recruited were between 25 and 60 years of age, who had been diagnosed with type 2 diabetes within the past 6 years, had a BMI of 27-45kg/m2 and were not receiving insulin. The intervention comprised with drawl of antihypertensive and anti diabetic drugs. Total diet replacement 825-853kcal/day formula diet for 3-5 months, stepped up food reintroduction (2-8 weeks) and structured support for long term weight loss maintenance. The study was run by local nurses or dieticians rather than by specialist staff. Fifteen hundred patients were invited by mail. 800 did not reply and more than 200 refused and 306 individuals agreed to take part in the trial. Only 8% lost to follow up in the 12 months. 86% in the intervention group and 99% in the control group attended the 12 month assessment. At 12 months weight loss of 15kg (24%) or more was found in 24% of participants. Diabetes remission was achieved in 68 (46%) of the participants and in the intervention group and 6 (4%) in the control group. 86% the 36 participant who lost 15kg or more achieved diabetes remission. 2 serious adverse events were seen in one patient (biliary colic and abdominal pain). They were deemed potentially related to the intervention. This trial demonstrates a feasible method of treating obesity at very little cost in a community setting.

There are of course many other methods that have some success in achieving weight reduction through calorie restriction but they are either poorly researched and/or have only very limited success. Intermittent food deprivation is a method which has had some popularity. Intermittent energy restriction is a potent stimulus for ketosis. In mice alternate day food deprivation has been shown to modulate molecular pathways involved in mitochondrial biogenesis, metabolism and cellular plasticity. These results lead to increased metabolic efficiency and indurance capacity [7]. Intermittent fasting in short term studies has been shown to reduce LDL cholesterol and increase HDL. These studies however are observational and lack detailed information about diet [8]. A recent review of weight loss strategies in people with and without diabetes came to the conclusion that intermittent fasting has a benefit beyond the weight loss produced and does not spare lean mass compared with daily energy restriction [9]. Another recent review also came to the conclusion that intermittent energy restriction was no better than continuous energy restriction for short term weight loss in obese adults. The authors suggest that although intermittent energy restriction was shown to be more effective than no treatment, this should be interpreted cautiously due to the small number of studies [10].

A recent study examined bariatric surgery vs. medical treatment with long-term medical complications and obesity related co-morbidities. The surgically treated patients had a greater likelihood of remission of hypertension and other co-morbidities including diabetes but a greater risk of new onset depression and other medical complications. The authors conclude that there should be careful consideration of the medical complications of surgery in their decision making [11]. The difficulties involved in treating obesity cannot be underestimated. Drug treatment with drugs such as GLP1 agonists have not been impressive A useful review on treatment options available for obesity has recently been published [12].

Many studies have suggested that different methods of monitoring of weight loss programmes are important for the limited success of these programmes. In a 12 month programme Jospe et al. [13] examined in 250 patients to see whether there would be a difference in our come between brief monthly individual consults, daily monitoring of weight, self monitoring of diet using My Fitness Pal, self monitoring of hunger or control. 68.4% of the study group of 250 adults with BMI 27 or greater completed the study. The study concluded that adding a monitoring strategy to diet and exercise advice did not further increase weight loss. Bupropion is a drug used in addiction. It stimulates hypothalamic pro-opiomelanocortin (POMC) neurones and reduces food intake and increases energy expenditure. Naloxone blocks POMC auto inhibition. The combination has been used to treat obesity. Aprovian et al [14] examined the effect of this combination and found that the combination reduced weight by 6, 4% as compared to a weight loss of 1.2% in the placebo arm. To date drug therapy for obesity treatment has been very disappointing. GLP1 agonists which delay gastric emptying as well as having a central effect on apatite. Three years of lira glutide versus placebo in patients with pre-diabetes and BMI of at least 30 has been reported [15-17]. More than 2000 patients were recruited. Only 50% of the patients completed the study. The subjects on Lira glutide lost 6.1% of body weight compared to the controls that lost 1.9%. A not very impressive treatment alas for obese patients.

In conclusion prevention of obesity, rather than treatment when present, would seem the way forward. The recent evidence is that the rising prevalence of obesity has been curbed in developed countries as has the rising prevalence of diabetes. It is likely that Government intervention with strategies to improve education curb advertising of unhealthy foods and tax reforms to decrease the cost of ‘Healthy food’ will succeed. Once obesity occurs bariatric surgery is the only very effective treatment but the mortality and morbidity means that patients have to be very carefully chosen. Very low calorie diets with supervision in a General Practice environment with minimal but regular support has been shown to be feasible.

Read More About Lupine Publishers Archives of Diabetes & Obesity (ADO) Please Click on Below Link:  https://diabetes-obesity-lupine-publishers.blogspot.com/


Tuesday, 6 July 2021

Lupine Publishers| Evaluation of the Prevalence of Gestational Diabetes Using Fasting Blood Glucose and Glycated Heamoglobin in Yenagoa Metropolis

 Lupine Publishers|  Archives of Diabetes & Obesity (ADO)


Abstract

There is understanding that most pregnant women with gestational diabetes mellitus stands the risk of having adverse obstetric and perinatal outcome. The need for an early detection and effective management of this problem with a view to ensure better maternal and fetal protection was the driving thrust for this study. Through the application of spectrophotometric methods employing enzymatic and non-enzymatic systems, the concentration of fasting blood glucose (FBG) and glycated Haemoglobin (HbA1c) were determined in 2nd and 3rd trimester pregnant women and compared with non-pregnant women. Data were analysed using student’s t-test with the aid of Graph pad Prism (R) software version 6.10 at p<0.05 values considered statistically significant. Result reveals that 11% of pregnant women investigated had gestational diabetes mellitus in Yenagoa metropolis. Our findings elucidate the danger of gestational diabetes mellitus, its prevalence and the need to allow for effective proactive intervention program regarding screening and management and in addition highlight areas requiring further research.

Keywords: Gestation; Diabetes mellitus; Fasting blood glucose; Glycated hemoglobin

Abbrevations: FBG: Fasting Blood Glucose; GDM: Gestational Diabetes Mellitus; RBC: Red Blood Cells; EDTA: Ethylene Diamine Tetrachloro Acetic Acid

Introduction

Diabetes mellitus is a group of metabolic disease conditions that have significantly contributed to increasing health burden and financial problem of many countries worldwide. Although the prevalence and screening methods for the two major clinical subgroups type 1 and type 2 diabetes are well researched and to a large extent, the mechanism are understood, other subgroups of this disease notably gestational diabetes mellitus (GDM) are less established. Gestational diabetes mellitus is defined as glucose intolerance of variable degree with onset or first recognition during pregnancy which as a concept, existed since 1964 [1,2] established that GDM occurs in about 2-10% of all pregnancies and the condition may improve or disappear after delivery. Studies of [3] have observed that GDM is estimated to affect 1% to 14% of pregnancies in the United States annually, depending on the population studied and the diagnosis test method used. It has been shown in [4] that gestational diabetes mellitus prevalence has been steadily increasing with the rise of obesity and type 2diabetes. Both birth certificates and pregnancy risk assessment monitoring system which include questionnaire completed by others can provide population based prevalence estimate of gestational diabetes mellitus.

Studies indicates that whereas specificity for gestational diabetes mellitus is high, on the birth certificate sensitivity is as low as 48%, thus gestational diabetes prevalence obtained from the birth certificate alone is likely underestimated. In contrast, pregnancy risk assessment monitoring system may overestimate GDM prevalence. The exact mechanism underlying GDM is still not clear. The hallmark of GDM however, is increased insulin resistance. As elucidated [5] pregnancy hormones and other factors are thought to interfere with the action of insulin as it readily binds to the insulin receptor. Insulin resistance is known to be a normal phenomenon which sparks up in the second trimester of pregnancy and progresses further thereafter to levels seen in non-pregnant patients with type 2 diabetes. It is unclear why some patients are unable to balance needs and develop GDM but it has been shown by [6] and [7] that autoimmunity, single gene mutations, obesity and other mechanism cannot be ruled out. Studies by [8-10] have ascribed this problem to loss of insulin producing beta cells of the islet of Langer hans. It had earlier been shown [11] that women with gestational diabetes are at high risk for pregnancy and delivery complications including infant macrosomia, neonatal hypoglycemia and cesarean delivery. Earlier work by [12] revealed that women who are affected by GDM have more increased risk of developing type 2 diabetes 5 to 10 years after delivery. It has also been shown by [13] that children born to mothers with gestational diabetes are also more likely to develop impaired glucose tolerance. It has been shown by [14] that glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three month average plasma glucose concentration. The test is limited to three months average plasma glucose concentration. This is because the life span of a red blood cell is four months about (120 days). However, since red blood cells (RBcs), do not all undergo lysis at the same time, glycated hemoglobin is taken as a limited measure of 3 months. Glycated hemoglobin is a measure of the beta-N-1-deoxyfructosyl component of hemoglobin. Previous report shows that normal levels of glucose produce a normal amount of glycated hemoglobin [15]. When blood glucose is high, glucose molecules attach to the hemoglobin in red cells. The longer hyperglycemia persists, the more glucose bind to the hemoglobin in the red blood cells and the higher the glycated hemoglobin. Once hemoglobin molecule is glycated, it remains that way. A build up of glycated hemoglobin within the red cell therefore reflect the average level of glucose to which cells have been exposed during its life-cycle.

Measuring glycated hemoglobin assesses the effectiveness of therapy by monitoring long-term glucose regulation. It has been shown that measurement of glycated hemoglobin is effective in monitoring long-term glucose control in people with diabetes mellitus [16]. It provides a retrospective index of the integrated plasma glucose values over an extended period of time and is not subject to the wide fluctuations observed when assaying blood glucose concentration. Our findings and implications for life of gestational diabetes mellitus patients are encapsulated in this work.

Material and Methods

Location/subjects

The study was conducted in Yenagoa, Bayelsa State, Nigeria among pregnant women in second and third trimester of pregnancy attending clinic in Diette Koki Hospital and Niger Delta University Teaching Hospital. The study population consisted of 100 pregnant women and 100 non-pregnant women that served as control.Ethical approval for this human study was obtained both from the Niger Delta University and the Diette Koki Hospital. Patients consent were sought for and agreed before sample collection commenced.

Samples

5.0ml of venous blood was collected from fasting subjects at 8.30am and the samples were ali quoted to fluoride bottle and ethylene diamine tetrachloro acetic acid (EDTA) containers. Sample in fluoride containers were spun to obtain serum for glucose determination. Samples in EDTA bottle were used for glycated hemoglobin (HbA1c) determination.

Analytical method

Glucose was determined by the glucose-oxidase-peroxidase method (Randox Product, UK). The glucose in sample was catalysed oxidatively by the glucose oxidase and converted to hydrogen peroxide and gluconic acid. The hydrogen peroxide was broken down by peroxidase and oxygen released reacts with 4-aminophenozone and phenol to give pink color whose absorbance was measured at 540nm with the use of spectrophotometer 22D+ (product of UNISCOPE, England). Glycated hemoglobin was determined nonenzymatically by first cleaving hemoglobin into peptides by the enzymes endoproteinase Glu-c, and in a second step by the glycated and non-glycated N-terminal hexa peptides of the ß–chain obtained were separated and quantified by ion-exchange high performance liquid chromatography (HPLC-Esi/ms) with UV-detection. Principle depend on the fact that a non-enzymatic reaction occurs between glucose and the N-terminal of the Beta-chain forming a Schiff base which is itself converted to 1-deoxyfructose an Amadori rearrangement. The longer hyperglycemia occurs in blood, the more glucose binds to hemoglobin and the higher the glycated hemoglobin concentration.

Statistical analysis

Data were analysed using student’s t-test with the aid of Graph pad Prism (R) software version 6.01 p values of <0.05 were considered statistically significant.

Result

The concentration of glucose and glycated hemoglobin in pregnant and non-pregnant subjects is shown in tables below. Table 1 is a one sample statistics for the pregnant women showing their glucose level and glycated hemoglobin. In Table 2 below show a comparison plot of glucose concentration in pregnant and nonpregnant. In Table 3 below a one sample statistics is shown for glycated hemoglobin concentration in pregnant and non-pregnant (Table 4) and (Figure 1).

Table 1: Glucose and HbA1c concentration.

lupinepublishers-openaccess-journal-diabetes-obesity

t=31.398, p=0.0001. P is significant at <0.05. Values on table suggest a relationship at p = 0.0001

Figure 1: Is a scatter plot showing the relationship of glucose with glycated hemoglobin. The plot shows that both parameters correlate positively.

lupinepublishers-openaccess-journal-diabetes-obesity

Table 2: Glucose concentration in pregnant and non-pregnant subjects.

lupinepublishers-openaccess-journal-diabetes-obesity

t=31.398, p=0.0001. P is significant at <0.05. Values on table suggest a relationship at p = 0.0001

Table 3: Glycated Haemoglobin in pregnant and non-pregnant.

lupinepublishers-openaccess-journal-diabetes-obesity

t=17.71, P=0.0001. P is significant at <0.05. Values on table suggest a relationship at p = 0.0001

Table 4: Glucose and glycated Haemoglobin concentration in non-pregnant.

lupinepublishers-openaccess-journal-diabetes-obesity

t=55.21. P=0.0001. P is significant at <0.05. Values on table suggest a relationship at p = 0.0001

Discussion

Concern for the health of the pregnant woman and he unborn child have driven the heightened interest in the investigation of gestational diabetes mellitus. The diagnostic criteria for gestational diabetes are varied and include screening of high risk patients, strong history of diabetes, and history of abnormal glucose metabolism, presence of glucosuria, diagnosis of polycystic ovarian syndrome, overweight and being a member of an ethnic/racial group with a high prevalence of diabetes mellitus. Pregnancy is known to induce a state of insulin resistance. This condition is usually elucidated especially at late pregnancy due to lowering of the renal threshold. Under this condition there is an increased demand on ß-cells function which may reveal sub-clinical aberrations in carbohydrate homeostasis which may not be normally apparent in a non-pregnant woman.

The present study which is the first of its kind undertaken in this part of the country showed the prevalence of GDM as 11%. It has however been reported variably from 1.4-14% worldwide and differently among racial and ethnic groups [3]. It was revealed that values obtained also depend on the population studied and the diagnostic test used [2]. Studies by [17] revealed that gestational diabetes mellitus rate differ by state with the greatest variation attributable to difference in obesity. Obesity is known to be associated with gestational diabetes and could be prevented if we reduce the risk of overweight women. Preventing obesity is a key component of good women care regardless of pregnancy intention.

We have used only those pregnant women whose glucose was close or above the threshold of 10.0mmol/l in this study in determining the prevalence on account of the criticality of the threshold value. The inclusion of the glycated hemoglobin in this study was intended to show how they correlate in GDM in consideration of the complications in diabetes. Earlier result [18] had epitomized this epidemiological profile of diabetics in pregnancy. The study by [19] also brought to the fore the need for care of diabetic mothers. It has also been recognized that most women with GDM revert back to normal glucose metabolism after delivery of their babies. It has however been observed that they stand the risk of developing type 2 diabetes later in life as are their offspring. Other common maternal complications include hypertension, vaginal candidiasis and abruption placenta with the possibility of macrosomia and stillbirths occurring in the fetus.

Our findings in this work are to a large extent at tandem with those found in the literature both at national and international level. The inference to be drawn from this study is that Yenagoa metropolis inspite of its differential ethnicity being a state capital, living standard, and variation in food is not significantly different from the diabetic incursion world over.

In conclusion, this work buttresses the need to initiate effective policy guidelines with intervention programmes to systematically structure and strengthen care for the pregnant woman and the fetus.

Read More About our Lupine Publishers Archives of Diabetes & Obesity (ADO) Please Click on Below Link: https://diabetes-obesity-lupine-publishers.blogspot.com/